Case Presentations

To fully appreciate the complexity and challenges in interpreting hypertension trials, it is informative to review their evolution. The prospective, randomized, clinical trial has been the foundation for evaluating the effectiveness of blood pressure-lowering drugs. The duration of clinical trials rarely exceeds five years, and trials focus on so-called “hard end points”—notably, all-cause mortality and/or cause specific morbidity and mortality due to CVD, usually coronary heart disease (CHD) and/or stroke, but more recently heart failure (HF) as well.

The early clinical trials had the advantage of being able to compare active therapywith placebo and usually included patients with more severe hypertension, as compared with modern trials. Consequently, they generated more end points and had sufficient power to be conducted on a smaller scale than modern trials high blood pressure is often called a "silent disease" because people usually don't know they have it; there may be no outward symptoms or a sign, so monitoring the blood pressure is critical. Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension treatment comes in many forms -- from lifestyle changes to medication.

  • Integrating lifestyle advice into clinical management
  • Meta-analysis of blood pressure-lowering drug trials
  • Reporting blood pressure parameters in clinical trails
  • Surrogate or intermediate disease markers
  • Primary biliary cirrhosis

Related Conference of Case Presentations

October 22-23, 2018

Global Cardiology Summit

Osaka, Japan
Oct 22- Oct 24 , 2018

27th European Cardiology Conference

Rome, Italy
November 05-06, 2018

28th World Congress on Cardiology and Heart Diseases


Hyatt Place Airport Hotel - Amsterdam, Netherlands
November 15-17, 2018

World Heart Rhythm Conference

Istanbul, Turkey
November 19-20, 2018

29th World Cardiology Conference

Edinburgh, Scotland
November 21-22, 2018

International Conference on Cardiovascular Diseases and Therapeutics

| Paris, France

Venue: Holiday Inn Paris - Marne la Vallée

November 21 - 22, 2018

6th World Congress on Hypertension and Public Health

Holiday Inn Paris - Marne la Vallé, 2 Boulevard du Levant, Noisy-le-Grand 93167
February 18-19, 2019

30th European Heart Diseases and Heart Failure Congress

Amsterdam, Netherlands
Feb 28-March 01, 2019

World Cardiology Experts Meeting

Osaka, Japan
March 15-16, 2019

4th Global Summit on Heart Diseases

Singapore
March 18-20, 2019

Middle East Heart Congress

Dubai, UAE
March 27- 28, 2019

5th World Heart Congress

Sydney, Australia
April 15 -16, 2019

5th World Heart Congress

Amsterdam, Netherlands
April 17-18, 2019

World Congress on Cardiac Surgery & Medical Devices 2019

Montreal | Quebec | Canada
April 19-20, 2019

World Heart and Brain Congress

Chicago, USA
April 25-26, 2019

2nd World Heart and Brain Conference

Helsinki, Finland
April 29 - May 01, 2019

4th World Heart Congress

Kyoto, Japan
June 17-19, 2019

31st Annual Cardiologists Conference

Rome, Italy
July 01-02, 2019

European Cardiology Congress

Prague | Czech Republic
July 10-11, 2019

25th World Cardiology Conference

Osaka, Japan
July 10-11,2019

26th Annual Cardiologists Conference

Osaka,Japan
July 26-27, 2019

4th International Conference on Hypertension and Healthcare

Melbourne, Australia
July 31-August 01, 2019

27th International Congress on Cardiology and medical interventions

Chicago, Illinois, USA

World Cardiology and Cardiologist Meet

August 5 - 7, 2019 Canne, France
August 19- 20, 2019

7th World Heart Congress

Vienna, Austria

Case Presentations Conference Speakers

Recommended Sessions

Related Journals

Are you interested in